Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

NCT02089828 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Thromboangiitis Obliterans
Arteritis
Peripheral Arterial Disease

Interventions

OTHER: autologous purified CD34+ cells
OTHER: autologous peripheral blood mononuclear cells

Sponsor

Shanghai Zhongshan Hospital